Literature DB >> 6853137

Acetylator phenotype in rheumatoid arthritis.

M Ehrenfeld, E Zylber-Katz, M Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6853137

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN： 0021-2180


× No keyword cloud information.
  5 in total

1.  Sulphasalazine therapy in RA.

Authors:  R S Amos; D E Bax; M S Greaves
Journal:  Ann Rheum Dis       Date:  1986-05       Impact factor: 19.103

Review 2.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

3.  Polymorphic acetylation: lack of influence of rheumatic disease activity and concomitant drug administration.

Authors:  C Astbury; C Beyeler; H A Bird
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

4.  Acetylator polymorphism in rheumatoid arthritis.

Authors:  J M Ladero; M P Andres; A Bañares; B Fernández; C Hernández; J Benítez
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.